Where does Pharma Integration S.R.L. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Pharma Integration S.R.L. ranks #49,568 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Pharma Integration S.R.L. hold?

Pharma Integration S.R.L. holds 5 US utility patents granted between 2022 and 2025, spanning 8 technology areas.

What is Pharma Integration S.R.L.'s Innovation Score?

Pharma Integration S.R.L. has an Innovation Score of 48.5 out of 100 (top 16% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Pharma Integration S.R.L. focus on?

Pharma Integration S.R.L.'s top technology area is B25J (MANIPULATORS; Chambers Provided With Manipulation Devices) with 4 patents, ranking #454 of 1,442 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Pharma Integration S.R.L.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Pharma Integration S.R.L..

What does claim depth mean for Pharma Integration S.R.L.'s patents?

Pharma Integration S.R.L.'s patents average 20.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Pharma Integration S.R.L. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Pharma Integration S.R.L.

USPTO PatentsView assignee record - 5 granted patents across 8 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B25J (MANIPULATORS; Chambers Provided With Manipulation Devices).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Pharma ranks #49,568 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 8 technology areas.

#49,568
of 49,997 US assignees by volume: Top 16%
by Innovation Score (48.5/100): 20.6
avg claims per patent

USPTO PatentsView assignee plate

Corpus R49568 · Foreign Corporation #49,568 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 5 grants
BOTTOM-DECILE #49,568/49,997
PHOTO-FINISH PF Loop
CPC-NARROW B25J · 8 areas
INNOV-PAR 48.5/100
CLAIMS-DENSE 20.6 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2022–2025 · 4y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: PF Loop, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Pharma’s 48.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (13%) Velocity 20.0 pts (41%) Breadth 10.0 pts (21%) Claim depth 12.4 pts (26%)

Qualcomm Incorporated · highest

85
Pharma Integration… · this assignee

49
3D Lighting… · lowest

7

What this shows Pharma's Innovation Score is 48.5/100 (top 16% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Pharma?

Each dot is one of Pharma’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Pharma’s own 20.6 claims/patent is ABOVE the 16.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Pharma vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Pharma's grants concentrate

Pharma Integration S.R.L. is a focused PatentsView assignee: 8 CPC subclasses with 80% of grants classified under B25J (MANIPULATORS; Chambers Provided With Manipulation Devices). Peak complete grant year is 2024 (3 grants) versus a trough of 1 in 2022. By volume, Pharma sits between PF Loop, Inc. and Philoptics Co., Ltd..

Pharma's three-year grant acceleration

Pharma Integration S.R.L. shows 4 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

PF Loop

5
PFW Aerospace

5
PGI International

5
Phagelux (Canada)

5
Pharmanutra S P A

5
Pharmaresearch

5
Pharosgen

5
Philoptics

5
Pharma Integratio… ◀

5

What this shows Pharma holds 5 patents at rank #49,502, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Pharma

By rank, the assignees closest to #49,502 in granted patent volume.

Leaders in B25J (Manipulators)

Other assignees with the most granted patents in Pharma's primary technology class.

Pharma's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 16% higher than 84% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2022–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table

Pharma Integration S.R.L. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2022	1	20.0%
2024	3	60.0%
2025partial year	1	20.0%

Which technologies does Pharma Integration S.R.L. patent most?

B25J - MANIPULATORS; Chambers Provided With Manipulation Devices 4

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 3

B08B - Cleaning IN GENERAL; Prevention OF Fouling IN General 2

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 2

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Pharma Integration S.R.L.'s patent record in context - here's where to go next.

Pharma Integration S.R.L.'s lead technology class is B25J (MANIPULATORS; Chambers Provided With Manipulation Devices), 80% of its portfolio - see every assignee active in that class. Explore B25J
Ranked #49,568 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Pharma Integration S.R.L. against PF Loop, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 48.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.